Suppr超能文献

胃腺癌中 E-钙黏蛋白、CD44 和 Claudin 7 的免疫表达。

Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas.

机构信息

Department of Pathology, Discipline of Pediatrics, Department of Infant Care-Pediatrics-Neonatology, University of Medicine and Pharmacy of Craiova, Romania;

出版信息

Rom J Morphol Embryol. 2022 Jul-Sep;63(3):529-537. doi: 10.47162/RJME.63.3.07.

Abstract

Gastric adenocarcinomas represent frequent malignant tumors in the digestive tract, with a high and constant mortality rate in last decades. The disturbance of the adhesion molecules expression, which normally is essential in maintaining epithelial homeostasis, has a critical role in the initiation and progression of tumors. In this study, we analyzed the immunoexpression of E-cadherin, cluster of differentiation 44 (CD44), and Claudin 7 in 58 cases of gastric adenocarcinomas, in relation to the histopathological parameters of the lesions' aggressiveness. Increased E-cadherin immunoexpression was observed in tubular adenocarcinomas, those of low grade and in stages I-III. CD44 presented high scores in discohesive, hepatoid, tubular, and tubulopapillary adenocarcinomas, those of high grade and in advanced stages. Claudin 7 associated increased scores for tubular, tubulopapillary and micropapillary tumors, those of low grade and mainly in stage I. The markers used in the study can be useful for assessing the aggressiveness of gastric adenocarcinomas, in the context of specific adapted therapy.

摘要

胃腺癌是消化道常见的恶性肿瘤之一,近几十年来死亡率一直居高不下。黏附分子的表达失调在肿瘤的发生和发展中起着关键作用,而这些分子的表达通常对于维持上皮细胞的内稳态是必不可少的。在这项研究中,我们分析了 58 例胃腺癌中 E-钙黏蛋白、CD44 簇和 Claudin 7 的免疫表达情况,与病变侵袭性的组织病理学参数有关。在管状腺癌、低级别和 I-III 期肿瘤中观察到 E-钙黏蛋白免疫表达增加。CD44 在离散型、肝样型、管状和管状乳头状腺癌、高级别和晚期肿瘤中得分较高。Claudin 7 与管状、管状乳头状和微乳头状肿瘤的高评分相关,这些肿瘤级别较低,主要处于 I 期。研究中使用的标志物可用于评估胃腺癌的侵袭性,以制定特定的适应性治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88da/9926152/c51301127e21/RJME-63-3-529-fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验